Scientific, Clinical and Commercial Development of RNA Therapeutics and Vaccines
October 18 @ 8:00 am - October 19 @ 5:00 pm
RNA medicines are at a critical moment in time. mRNA vaccines dominate the headlines in the wake of the COVID-19 pandemic.
But huge advances are also being made in RNAi and antisense technologies. Our understanding of RNA chemistry continues to mature. Delivery tools are increasingly sophisticated and impactful.
Advances in genomics and gene editing are driving new approaches. And exciting work targeting RNA with small molecules is emerging.
With that in mind, we can’t wait to bring the community together, face-to-face, for the RNA Leaders USA Congress.